共 5 条
- [1] Intraperitoneally Administered Neo-islets, Aggregates of Mesenchymal Stem Cells, and Cultured Islet Cells Improve Glycemic Control of Spontaneously Occurring Insulin-Dependent Diabetes Mellitus in Pet Dogs-A Pilot Study, INAD 012-776DIABETES, 2018, 67Westenfelder, ChristofGooch, AnnaSon, Natasha K. LoyAvila, NicoleFischer, Julie R.
- [2] Interim report on the effective intraperitoneal therapy of insulin-dependent diabetes mellitus in pet dogs using "Neo-Islets," aggregates of adipose stem and pancreatic islet cells (INAD 012-776)PLOS ONE, 2019, 14 (09):Gooch, AnnaZhang, PingHu, ZhumaSon, Natasha LoyAvila, NicoleFischer, JulieRoberts, GregorySellon, RanceWestenfelder, Christof
- [3] Scientific Basis for the First-in-Human Trial of "Neo-Islet"-Mediated Functional Cure of T1DM: The Intraperitoneal Administration of "Neo-Islets," 3-D Organoids of Allogeneic Islet and Mesenchymal Stromal Cells from Rodents, Dogs, and Humans Durably CuresDIABETES, 2022, 71Westenfelder, ChristofChowdhury, Sabiha S.Gooch, Anna
- [5] Effective and Durable Stem-Cell-Enabled Therapy of Autoimmune T1DM in Rodents and Dogs Provides the Scientific Basis for the First-in-Human Trial Using I. P. Administered "Neo-Islets," 3-D Organoids of Allogeneic Islet, and Mesenchymal Stromal Cells-The Omentum Becomes the New Endocrine Pancreas without the Need for Antirejection DrugsDIABETES, 2023, 72Gooch, AnnaWestenfelder, Christof